1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow tinostamustine: new trials by email Literature Review of tinostamustine trials Research Report on tinostamustine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors. Tinostamustine 60mg/m2 over 30min, Tinostamustine 80mg/m2 over 30min, Tinostamustine 100mg/m2 over 30min - Small Cell Lung Cancer, Soft Tissue Sarcoma | Phase 1 / Phase 2 | Completed | Mundipharma Research Limited | 71 | 2017-11-08 | 2024-10-21 |
Breast Neoplasms (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Recurrence (1) · Sarcoma (1) · Small Cell Lung Carcinoma (1) · Triple Negative Breast Neoplasms (1)
Mundipharma Research Limited (1)
Canada (1) · Italy (1) · Netherlands (1) · Spain (1) · United States (1)
Ana Oaknin, MD (1) · Shivaani Kummar, MD (1)